Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 12 01 2018
accepted: 26 06 2018
pubmed: 10 7 2018
medline: 23 2 2019
entrez: 9 7 2018
Statut: ppublish

Résumé

A patient's physical function is a critical outcome variable for measuring and improving chronic care management. However, patient-reported outcome measures of physical function are not routinely assessed in cancer outpatients, in part due to limitations of tools available. This study presents the development and evaluation of the Cancer Ambulatory Patient Physical Function Longitudinal Evaluation Tool (CAPLET) as an adaptive response tool for routinely screening for physical dysfunction in oncology clinical practice. In phase 1, 407 adult outpatients at Princess Margaret Cancer Centre completed the World Health Organization Disability Assessment Schedule (WHODAS) 2.0, Health Assessment Questionnaire Disability Index (HAQ-DI), EuroQuol-5D-3L ( EQ-5D-3L), and patient-reported outcome (PRO)-Eastern Cooperative Oncology Group (ECOG). CAPLET was developed based on a branching logic algorithm navigating patients to appropriate domains of HAQ-DI/WHOAS using their responses to the PRO-ECOG/EQ-5D-3L as screeners. Sensitivity/specificity of CAPLET screeners for HAQ-DI/WHODAS items were reported. In phase 2, CAPLET vs the WHODAS/HAQ-DI were alternatively administrated to 318 adult outpatients in a two-arm trial comparing time to completion and acceptability between the tools. Using a patient's ECOG status and the sum of the mobility, self-care, and usual activity dimensions of the EQ-5D-3L to dichotomize patients as with or without difficulty, CAPLET achieved a sensitivity > 90% against recommended WHODAS and HAQ-DI cutoffs for significant dysfunction. Sensitivity of screeners for capturing dysfunction in individual WHODAS/HAQ-DI items ranged from 85 to 100%. Compared to the HAQ-DI/WHODAS, CAPLET was associated with a 50% reduction in administration times and improved patient acceptability, while reducing question burden by 84% for half the sample population. CAPLET improves the feasibility of capturing detailed assessments of patient-reported physical function in cancer outpatients.

Identifiants

pubmed: 29982902
doi: 10.1007/s00520-018-4333-8
pii: 10.1007/s00520-018-4333-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-530

Références

J Clin Oncol. 2002 Jan 15;20(2):494-502
pubmed: 11786579
Health Qual Life Outcomes. 2003 Jun 09;1:20
pubmed: 12831398
Arthritis Rheum. 2004 Mar;50(3):953-60
pubmed: 15022339
Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii40-ii45
pubmed: 15479870
J Pain Symptom Manage. 2009 Feb;37(2):196-205
pubmed: 18619767
Oncology (Williston Park). 2008 Jul;22(8):916-22; discussion 925, 928
pubmed: 18709902
Phys Ther. 2009 Mar;89(3):286-306
pubmed: 19147708
PLoS One. 2009 Dec 17;4(12):e8343
pubmed: 20020047
Health Qual Life Outcomes. 2009 Dec 23;7:102
pubmed: 20030832
Eur J Cancer. 2010 May;46(8):1352-8
pubmed: 20231085
Health Qual Life Outcomes. 2010 May 19;8:51
pubmed: 20482853
Psychooncology. 2012 Apr;21(4):357-64
pubmed: 21308858
J Neuroeng Rehabil. 2012 Apr 20;9:21
pubmed: 22520559
Healthc Pap. 2011;11(4):8-18; discussion 55-8
pubmed: 22543287
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007566
pubmed: 22895961
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
JAMA. 2013 Jul 10;310(2):139-40
pubmed: 23839744
Value Health. 2014 Jan-Feb;17(1):70-6
pubmed: 24438719
J Oncol Pract. 2014 May;10(3):209-11
pubmed: 24756142
N C Med J. 2014 Jul-Aug;75(4):283-6
pubmed: 25046097
J Palliat Care. 2014 Summer;30(2):99-107
pubmed: 25058987
J Natl Cancer Inst. 2014 Sep 29;106(9):null
pubmed: 25265940
PLoS One. 2014 Dec 26;9(12):e115413
pubmed: 25542042
Ann Oncol. 2015 Sep;26(9):1846-58
pubmed: 25888610
Clin Cancer Res. 2016 Apr 1;22(7):1553-8
pubmed: 26758559
J Geriatr Oncol. 2016 Mar;7(2):108-15
pubmed: 26907563
AMIA Annu Symp Proc. 2015 Nov 05;2015:320-8
pubmed: 26958163
Clin Ther. 2016 Apr;38(4):769-77
pubmed: 27041407
J Med Internet Res. 2016 Sep 30;18(9):e240
pubmed: 27694100
J Popul Ther Clin Pharmacol. 2016 Sep 13;23(3):e196-e204
pubmed: 27783475
Disabil Rehabil. 2017 Nov;39(23):2347-2380
pubmed: 27820966
J Am Med Inform Assoc. 2017 Sep 1;24(5):897-902
pubmed: 28444397
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390

Auteurs

Elizabeth Hall (E)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Emily Tam (E)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Mindy Liang (M)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Quihuang Zhang (Q)

Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Lin Liu (L)

Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Lauren Wong (L)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Samantha Sarabia (S)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Sabrina Yeung (S)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Gursharan Gill (G)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Lawson Eng (L)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Andrea Perez-Cosio (A)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

M Catherine Brown (MC)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Wei Xu (W)

Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Madeline Li (M)

Psychosocial Oncology, Princess Margaret Cancer Centre, 610 University Ave., 7-124, Toronto, Ontario, M5G 2M9, Canada.

Nicole Mittmann (N)

Sunnybrook Health Sciences Centre, Toronto, Canada.

Jennifer Jones (J)

Survivorship Program, Princess Margaret Cancer Centre, Toronto, Canada.

Doris Howell (D)

Psychosocial Oncology, Princess Margaret Cancer Centre, 610 University Ave., 7-124, Toronto, Ontario, M5G 2M9, Canada. Doris.Howell@uhn.ca.
Lawrence Bloomberg School of Nursing, University of Toronto, Toronto, Canada. Doris.Howell@uhn.ca.

Geoffrey Liu (G)

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Geoffrey.Liu@uhn.ca.
Department of Epidemiology, Dalla Lana School of Public Health, Departments of Medicine and Biophysics, University of Toronto, Toronto, Canada. Geoffrey.Liu@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH